|

Larsucosterol Clinical Trials

1 actively recruiting trial across 1 location

Also known as: DUR928, DV928

Pipeline

Phase 3: 1

Top Sponsors

  • Bausch Health Americas, Inc.1

Indications

  • Liver Disease1
  • Hepatitis1

Dallas, Texas1 trial

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

The Liver Institute at Methodist Dallas Medical Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.